Misplaced Pages

DMeOB: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 08:19, 30 September 2010 editAlvin Seville (talk | contribs)Extended confirmed users, Pending changes reviewers33,089 edits removing and categorizing← Previous edit Latest revision as of 16:26, 23 September 2024 edit undoJWBE (talk | contribs)Extended confirmed users10,127 edits added Category:3-Methoxyphenyl compounds using HotCat 
(21 intermediate revisions by 16 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox
{{Drugbox
| IUPAC_name = 1-(3-methoxyphenyl)-N-methanimine
| Verifiedfields = changed
| image = DMeOB_structure.png
| Watchedfields = changed
| width = 200
| verifiedrevid = 387877002
| CAS_number = 40252-74-2
| IUPAC_name = 1-(3-methoxyphenyl)-N-methanimine
| ATC_prefix =
| image = DMeOB_structure.png
| ATC_suffix =
| width = 220
| PubChem = 6891506
| image2 = DMeOB 3D spacefill.png
| DrugBank =
| width2 = 240
| C=16|H=16|N=2|O=2
| alt2 = Space-filling model of the DMeOB
| molecular_weight = 268.310 g/mol

| smiles = COc2cc(ccc2)C=NN=Cc1cccc(OC)c1
<!--Clinical data-->
| bioavailability =
| protein_bound = | tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| metabolism =
| pregnancy_US = <!-- A / B / C / D / X -->
| elimination_half-life =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| pregnancy_US = <!-- A / B / C / D / X --> | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| pregnancy_category=

| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
<!--Identifiers-->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| CAS_number_Ref = {{cascite|correct|??}}
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| CAS_number = 40252-74-2
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| PubChem = 6891506
| legal_status =
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| routes_of_administration =
| ChemSpiderID = 5277863
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C16H16N2O2/c1-19-15-7-3-5-13(9-15)11-17-18-12-14-6-4-8-16(10-14)20-2/h3-12H,1-2H3/b17-11+,18-12+
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = FBNPHFBYHYNMHC-JYFOCSDGSA-N

<!--Chemical data-->
| C=16 | H=16 | N=2 | O=2
| smiles = COc2cc(ccc2)C=NN=Cc1cccc(OC)c1
}} }}


'''DMeOB''' is a drug used in scientific research which acts as a ] of the ] subtype ].<ref name="pmid12920211">{{cite journal |author=O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL |title=A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5 |journal=Molecular Pharmacology |volume=64 |issue=3 |pages=731–40 |year=2003 |month=September |pmid=12920211 |doi=10.1124/mol.64.3.731 |url= |issn=}}</ref> '''DMeOB''' is a drug used in scientific research which acts as a ] of the ] subtype ].<ref name="pmid12920211">{{cite journal |vauthors=O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL |title=A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5 |journal=Molecular Pharmacology |volume=64 |issue=3 |pages=731–40 |date=September 2003 |pmid=12920211 |doi=10.1124/mol.64.3.731 }}</ref>

==References==
{{Reflist|2}}


{{Metabotropic glutamate receptor modulators}}
== References ==
{{Reflist}}


]
{{Glutamate_receptor_ligands}}
]
]
]


{{pharma-stub}}


{{nervous-system-drug-stub}}
]
]
]